- Home
- CVNA vs ALC Comparison
CVNA vs ALC Comparison
Compare CVNA & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVNA
- ALC
- Stock Information
- Founded
- CVNA 2012
- ALC 1945
- Country
- CVNA United States
- ALC Switzerland
- Employees
- CVNA N/A
- ALC N/A
- Industry
- CVNA Other Specialty Stores
- ALC Ophthalmic Goods
- Sector
- CVNA Consumer Discretionary
- ALC Health Care
- Exchange
- CVNA Nasdaq
- ALC Nasdaq
- Market Cap
- CVNA 46.0B
- ALC 43.7B
- IPO Year
- CVNA 2017
- ALC N/A
- Fundamental
- Price
- CVNA $349.51
- ALC $86.99
- Analyst Decision
- CVNA Buy
- ALC Buy
- Analyst Count
- CVNA 18
- ALC 10
- Target Price
- CVNA $302.83
- ALC $107.00
- AVG Volume (30 Days)
- CVNA 3.6M
- ALC 1.5M
- Earning Date
- CVNA 07-30-2025
- ALC 08-19-2025
- Dividend Yield
- CVNA N/A
- ALC 0.25%
- EPS Growth
- CVNA 87.85
- ALC 6.66
- EPS
- CVNA 2.97
- ALC 2.25
- Revenue
- CVNA $14,844,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- CVNA $32.22
- ALC $6.22
- Revenue Next Year
- CVNA $21.86
- ALC $7.16
- P/E Ratio
- CVNA $118.21
- ALC $38.42
- Revenue Growth
- CVNA 32.23
- ALC 3.80
- 52 Week Low
- CVNA $118.50
- ALC $80.48
- 52 Week High
- CVNA $364.00
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- CVNA 61.90
- ALC 46.73
- Support Level
- CVNA $342.70
- ALC $86.94
- Resistance Level
- CVNA $364.00
- ALC $89.52
- Average True Range (ATR)
- CVNA 13.30
- ALC 1.22
- MACD
- CVNA 1.77
- ALC 0.14
- Stochastic Oscillator
- CVNA 78.00
- ALC 51.06
About CVNA Carvana Co.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.